GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ShareHope Medicine Co Ltd (ROCO:8403) » Definitions » Piotroski F-Score

ShareHope Medicine Co (ROCO:8403) Piotroski F-Score : 7 (As of Apr. 07, 2025)


View and export this data going back to 2011. Start your Free Trial

What is ShareHope Medicine Co Piotroski F-Score?

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ShareHope Medicine Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for ShareHope Medicine Co's Piotroski F-Score or its related term are showing as below:

ROCO:8403' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of ShareHope Medicine Co was 7. The lowest was 4. And the median was 6.


ShareHope Medicine Co Piotroski F-Score Historical Data

The historical data trend for ShareHope Medicine Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ShareHope Medicine Co Piotroski F-Score Chart

ShareHope Medicine Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 6.00 4.00 7.00

ShareHope Medicine Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 6.00 9.00 7.00

Competitive Comparison of ShareHope Medicine Co's Piotroski F-Score

For the Medical Distribution subindustry, ShareHope Medicine Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ShareHope Medicine Co's Piotroski F-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ShareHope Medicine Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where ShareHope Medicine Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 24.529 + 71.164 + 16.745 + 87.659 = NT$200 Mil.
Cash Flow from Operations was 35.647 + 104.494 + 66.137 + 60.397 = NT$267 Mil.
Revenue was 972.549 + 1091.74 + 1149.776 + 1111.766 = NT$4,326 Mil.
Gross Profit was 171.255 + 197.519 + 174.534 + 171.096 = NT$714 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(7445.538 + 7354.343 + 7353.247 + 7123.785 + 7101.717) / 5 = NT$7275.726 Mil.
Total Assets at the begining of this year (Dec23) was NT$7,446 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1,204 Mil.
Total Current Assets was NT$3,392 Mil.
Total Current Liabilities was NT$1,860 Mil.
Net Income was 37.404 + 32.787 + 9.672 + 44.694 = NT$125 Mil.

Revenue was 896.258 + 941.17 + 969.074 + 1066.882 = NT$3,873 Mil.
Gross Profit was 167.054 + 188.398 + 147.292 + 223.633 = NT$726 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(7377.756 + 7273.727 + 7044.344 + 7410.365 + 7445.538) / 5 = NT$7310.346 Mil.
Total Assets at the begining of last year (Dec22) was NT$7,378 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1,456 Mil.
Total Current Assets was NT$3,240 Mil.
Total Current Liabilities was NT$1,965 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ShareHope Medicine Co's current Net Income (TTM) was 200. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ShareHope Medicine Co's current Cash Flow from Operations (TTM) was 267. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=200.097/7445.538
=0.02687475

ROA (Last Year)=Net Income/Total Assets (Dec22)
=124.557/7377.756
=0.01688278

ShareHope Medicine Co's return on assets of this year was 0.02687475. ShareHope Medicine Co's return on assets of last year was 0.01688278. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

ShareHope Medicine Co's current Net Income (TTM) was 200. ShareHope Medicine Co's current Cash Flow from Operations (TTM) was 267. ==> 267 > 200 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=1204.431/7275.726
=0.16554101

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=1455.592/7310.346
=0.19911397

ShareHope Medicine Co's gearing of this year was 0.16554101. ShareHope Medicine Co's gearing of last year was 0.19911397. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=3392.392/1859.999
=1.82386765

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=3239.624/1964.972
=1.64868711

ShareHope Medicine Co's current ratio of this year was 1.82386765. ShareHope Medicine Co's current ratio of last year was 1.64868711. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

ShareHope Medicine Co's number of shares in issue this year was 132.098. ShareHope Medicine Co's number of shares in issue last year was 131.193. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=714.404/4325.831
=0.16514838

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=726.377/3873.384
=0.18753034

ShareHope Medicine Co's gross margin of this year was 0.16514838. ShareHope Medicine Co's gross margin of last year was 0.18753034. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=4325.831/7445.538
=0.58099643

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=3873.384/7377.756
=0.52500842

ShareHope Medicine Co's asset turnover of this year was 0.58099643. ShareHope Medicine Co's asset turnover of last year was 0.52500842. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+0+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ShareHope Medicine Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

ShareHope Medicine Co  (ROCO:8403) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


ShareHope Medicine Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of ShareHope Medicine Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ShareHope Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
No.168 Chingkuo Road, 19th Floor, Taoyuan, TWN
ShareHope Medicine Co Ltd is engaged in providing wholesale and retail sales of medicines and hygiene materials, leasing assets for medical institutions to undertake related medical services and physical examinations for Taiwanese people and foreign laborers, on-site medical support services, hemodialysis business management, and ophthalmic medical management in collaboration with medical institutions. The company also provides a pharmaceutical procurement platform for medicines, health materials, and home care products. The company's revenue mainly stems from medicine and medical material sales, alongside service income from physical examinations for Taiwanese citizens and foreign laborers, on-site medical support, hemodialysis management, and ophthalmic collaborations.

ShareHope Medicine Co Headlines

No Headlines